# Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

> **NCT04305613** · — · ACTIVE_NOT_RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 221 (estimated)

## Conditions studied

- Cardiotoxicity
- Lung Cancer Stage III
- Lung Cancer Stage II
- Radiation Toxicity

## Interventions

- **OTHER:** Chemoradiation

## Key facts

- **NCT ID:** NCT04305613
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-14
- **Primary completion:** 2026-09
- **Final completion:** 2030-12
- **Target enrollment:** 221 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305613, "Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04305613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*